Market Overview

UPDATE: Goldman Sachs Resumes Coverage on Plexus on Margin and ROIC Upside

Related PLXS
Earnings Scheduled For January 18, 2017
Benzinga's Top Upgrades, Downgrades For December 15, 2016
New Stocks On Exec Comp And ROIC Model Portfolio: February 2017 (Seeking Alpha)

In a report published Wednesday, Goldman Sachs analyst Mark Delaney resumed coverage on Plexus Corp. (NASDAQ: PLXS) with a Buy rating and $42.00 price target.

In the report, Goldman Sachs noted, “We resume coverage of Plexus with a Buy rating and a 6-month price target of $42 (12% upside). Plexus has lagged EMS peers (it is up 24% yoy vs. the peer average of up 61% yoy), likely driven by its announcement in November 2012 that its historically largest customer Juniper (16% of revenue) was leaving to consolidate with fewer suppliers. In addition, sales to Coke (formerly a large customer) have been well below prior levels due to weak sell-through of the Coke freestyle machine. We believe this creates an opportunity. (1) Plexus's revenue growth profile is de-risked, and it now has about 70% of sales tied to high-mix end markets. (2) We expect Plexus to expand margins and ROIC in 2014 due to the increased percentage of high-mix business and reduced capex on facility consolidations. (3) We believe Plexus is a potential M&A candidate given its exposure to high-mix markets where its larger competitors have been doing M&A.”

Plexus Corp. closed on Tuesday at $37.66.

Latest Ratings for PLXS

Dec 2016Longbow ResearchDowngradesBuyNeutral
Jul 2016B. RileyDowngradesBuyNeutral
Jun 2016CitigroupMaintainsNeutral

View More Analyst Ratings for PLXS
View the Latest Analyst Ratings

Posted-In: Goldman Sachs Mark DelaneyAnalyst Color Initiation Analyst Ratings


Related Articles (PLXS)

View Comments and Join the Discussion!